药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Mechlorethamine
Gilteritinib
The risk or severity of adverse effects can be increased when Gilteritinib is combined with Pancuronium.
Mechlorethamine
Dacomitinib
The risk or severity of adverse effects can be increased when Dacomitinib is combined with Pancuronium.
Mechlorethamine
Pitolisant
The risk or severity of adverse effects can be increased when Pitolisant is combined with Pancuronium.
Mechlorethamine
Palbociclib
The risk or severity of adverse effects can be increased when Palbociclib is combined with Pancuronium.
Mechlorethamine
Linagliptin
The risk or severity of adverse effects can be increased when Linagliptin is combined with Pancuronium.
Mechlorethamine
Choline salicylate
The risk or severity of adverse effects can be increased when Pancuronium is combined with Choline salicylate.
Mechlorethamine
Nafamostat
The risk or severity of adverse effects can be increased when Pancuronium is combined with Nafamostat.
Mechlorethamine
Dexchlorpheniramine maleate
The risk or severity of adverse effects can be increased when Pancuronium is combined with Dexchlorpheniramine maleate.
Mechlorethamine
Histamine
The risk or severity of adverse effects can be increased when Pancuronium is combined with Histamine.
Mechlorethamine
Buformin
The risk or severity of adverse effects can be increased when Pancuronium is combined with Buformin.
Mechlorethamine
Spermidine
The risk or severity of adverse effects can be increased when Pancuronium is combined with Spermidine.
Mechlorethamine
Acetylcholine
The risk or severity of adverse effects can be increased when Pancuronium is combined with Acetylcholine.
Mechlorethamine
Pirlimycin
The risk or severity of neuromuscular blockade can be increased when Pirlimycin is combined with Pancuronium.
Mechlorethamine
Cannabinol
The risk or severity of adverse effects can be increased when Cannabinol is combined with Pancuronium.
Mechlorethamine
Palmidrol
The risk or severity of adverse effects can be increased when Palmidrol is combined with Pancuronium.
Mechlorethamine
Nabiximols
The risk or severity of adverse effects can be increased when Nabiximols is combined with Pancuronium.
Mechlorethamine
WIN 55212-2
The risk or severity of adverse effects can be increased when WIN 55212-2 is combined with Pancuronium.
Mechlorethamine
Surinabant
The risk or severity of adverse effects can be increased when Surinabant is combined with Pancuronium.
Mechlorethamine
Ibipinabant
The risk or severity of adverse effects can be increased when Ibipinabant is combined with Pancuronium.
Mechlorethamine
Ajulemic acid
The risk or severity of adverse effects can be increased when Ajulemic acid is combined with Pancuronium.